The 2026 SkinCeuticals acne update centers on two salicylic-acid serums, Blemish + Age Defense and Silymarin CF Acne Treatment. FDA label mirrors describe blemish reduction and healing support, while the Journal of Cosmetic Dermatology acne data remain limited to a small open-label pilot.
The pilot tested mild-to-moderate acne, reports the Journal of Cosmetic Dermatology. The American Academy of Dermatology, summarized by Managed Healthcare Executive, places salicylic acid as a conditional option behind stronger first-line drugs. Formula details, study limits, and storage habits shape practical choices.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What these serums contain
- What the Silymarin CF pilot proves
- Where guidelines place salicylic acid
- What heat and benzene mean for you
What these serums contain
The FDA DailyMed label mirror lists Blemish + Age Defense as an over-the-counter treatment with salicylic acid as the active ingredient. Its labeled use is reducing acne blemishes and allowing skin to heal, described in the Blemish + Age Defense label.
The FDA DailyMed label mirror also lists Silymarin CF Acne Treatment as a 0.5% salicylic acid solution for reducing blemish number and severity, described in the Silymarin CF label. The Journal of Cosmetic Dermatology pilot describes the tested serum as 0.5% silymarin with 15% L-ascorbic acid, 0.5% ferulic acid, and 0.5% salicylic acid. It calls the formula an adjuvant cosmeceutical, meaning a skincare product used alongside standard acne drugs.
What the Silymarin CF pilot proves
The Journal of Cosmetic Dermatology reports a prospective, open-label pilot study in mild-to-moderate acne. Open-label means doctors and patients knew the treatment assignment.
Without blinding, a control arm, and large enrollment, the trial cannot prove standalone efficacy. Readers considering it can view results as early support for combination use. A dermatologist can judge whether an add-on fits the current prescription plan.
Where guidelines place salicylic acid
The American Academy of Dermatology 2024 guidelines, summarized by Managed Healthcare Executive, strongly recommend topical benzoyl peroxide, retinoids, antibiotics and combinations plus oral isotretinoin for severe acne. The same summary gives conditional recommendations to salicylic acid, clascoterone, azelaic acid and sarecycline, detailed in the guidelines summary.
Cost shaped some conditional calls, reports Managed Healthcare Executive. GoodRx prices around $604 for Winlevi and $1,089 for Seysara limited stronger support. That cost burden affects equitable access for acne patients.
What heat and benzene mean for you
The U.S. Food and Drug Administration tested 95 benzoyl-peroxide acne products in 2025. More than 90% had undetectable or extremely low benzene.
A small number with elevated benzene faced retail-level voluntary recall. The Acne and Rosacea Society of Canada notes benzoyl peroxide can degrade into benzene especially at higher temperatures. Practical steps reduce that risk during daily use. SkinCeuticals salicylic-acid acne products do not rely on benzoyl peroxide.
- keep acne products away from heat and sun-exposed cars
- follow label storage instructions exactly
- check recall notices for benzoyl-peroxide products in the cabinet